Solera Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -5.57%
(FY 2022)
- Profit -8535.75%
(FY 2022)
- Ebitda -1926.38%
(FY 2022)
- Net Worth -64.35%
(FY 2022)
- Total Assets -8.37%
(FY 2022)
About Solera Life Sciences
The Corporate was formerly known as Solera Lifescience Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sirey Kothary, Manish Kothary, and Dinesh Khurana serve as directors at the Company.
- CIN/LLPIN
U52311DL2016PTC302269
- Company No.
302269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2016
- Date of AGM
10 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Solera Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirey Kothary  | Director | 29-Jun-2016 | Current |
| Manish Kothary | Additional Director | 01-Nov-2024 | Current |
| Dinesh Khurana | Director | 29-Jun-2016 | Current |
Financial Performance of Solera Life Sciences.
Solera Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.57% decrease. The company also saw a substantial fall in profitability, with a 8535.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 64.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solera Life Sciences?
In 2020, Solera Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Calyco Products Private LimitedActive 1 year 8 monthsSirey Kothary and Manish Kothary are mutual person
- Internet Innovations India Private LimitedActive 26 years 10 months
Sirey Kothary and Manish Kothary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Solera Life Sciences?
Unlock and access historical data on people associated with Solera Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solera Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solera Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
